Search
Amgen Inc
AMGNAdd to Watchlist
337.600USD
-4.060-1.19%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
182.20BMarket Cap
23.31P/E TTM
Revenue Breakdown
Currency: USDUpdated: Thu, Apr 2
Currency: USDUpdated: Thu, Apr 2
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Other products
7.26B
19.76%
Prolia
4.41B
12.01%
Repatha
3.02B
8.21%
Otezla
2.27B
6.16%
Enbrel
2.23B
6.06%
Other
17.57B
47.80%
By RegionUSD
Name
Revenue
Proportion
US
25.66B
69.81%
ROW
9.49B
25.83%
Other revenues
1.60B
4.36%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Other products
7.26B
19.76%
Prolia
4.41B
12.01%
Repatha
3.02B
8.21%
Otezla
2.27B
6.16%
Enbrel
2.23B
6.06%
Other
17.57B
47.80%
